Company Filing History:
1 out of 12 
1 out of 10 Years Active: 2014
Title: Márcia Fantini: Innovator in Immunogenical Complexes
Introduction
Márcia Fantini is a notable inventor based in São Paulo, Brazil. He has made significant contributions to the field of immunology through his innovative work on immunogenical complexes. His research focuses on enhancing the efficacy of vaccines by utilizing advanced materials.
Latest Patents
Fantini holds a patent for an "Immunogenical complex formed by vaccinal antigens encapsulated by nanostructured mesoporous silica." This invention relates to a product known as the immunogenical complex, which comprises an adjuvant characterized by solid particles of highly ordered nanostructured mesoporous silica, preferably SBA-15 Silica, and various vaccinal antigens encapsulated within these adjuvants. The immunogenical complex allows for the safe, gradual, and extended presentation of antigens to lymphocytes, leading to improved immunological memory and increased immunogenicity. This innovation ensures efficient immunological protection with reduced amounts of antigens and fewer repetitions of vaccine doses.
Career Highlights
Throughout his career, Márcia Fantini has worked with prominent companies such as Cristalia Produtos Químicos Farmacêuticos Ltda. and Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP). His work in these organizations has contributed to advancements in pharmaceutical research and development.
Collaborations
Fantini has collaborated with esteemed colleagues, including Ogari Pacheco and Osvaldo Augusto Sant'Anna. These partnerships have fostered a collaborative environment that enhances the innovation process in his field.
Conclusion
Márcia Fantini's contributions to immunology through his patented innovations demonstrate his commitment to advancing vaccine technology. His work not only improves immunological responses but also paves the way for more effective vaccination strategies.